ArticleCancer research and treatment2022

Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non-Small Cell Lung Cancer.

Shinkyo Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.